Merchant, H.J.; Forteath, C.; Gallagher, J.R.; Dinkova-Kostova, A.T.; Ashford, M.L.J.; McCrimmon, R.J.; McNeilly, A.D.
Activation of the Nrf2 Pathway by Sulforaphane Improves Hypoglycaemia-Induced Cognitive Impairment in a Rodent Model of Type 1 Diabetes. Antioxidants 2025, 14, 308.
https://doi.org/10.3390/antiox14030308
AMA Style
Merchant HJ, Forteath C, Gallagher JR, Dinkova-Kostova AT, Ashford MLJ, McCrimmon RJ, McNeilly AD.
Activation of the Nrf2 Pathway by Sulforaphane Improves Hypoglycaemia-Induced Cognitive Impairment in a Rodent Model of Type 1 Diabetes. Antioxidants. 2025; 14(3):308.
https://doi.org/10.3390/antiox14030308
Chicago/Turabian Style
Merchant, Heather J., Calum Forteath, Jennifer R. Gallagher, Albena T. Dinkova-Kostova, Michael L. J. Ashford, Rory J. McCrimmon, and Alison D. McNeilly.
2025. "Activation of the Nrf2 Pathway by Sulforaphane Improves Hypoglycaemia-Induced Cognitive Impairment in a Rodent Model of Type 1 Diabetes" Antioxidants 14, no. 3: 308.
https://doi.org/10.3390/antiox14030308
APA Style
Merchant, H. J., Forteath, C., Gallagher, J. R., Dinkova-Kostova, A. T., Ashford, M. L. J., McCrimmon, R. J., & McNeilly, A. D.
(2025). Activation of the Nrf2 Pathway by Sulforaphane Improves Hypoglycaemia-Induced Cognitive Impairment in a Rodent Model of Type 1 Diabetes. Antioxidants, 14(3), 308.
https://doi.org/10.3390/antiox14030308
